Eventackle | Intelligence

Tata Unveils Plans For Multiple EV Launches, Including The Curvv In 2024

08 August, 2023: Tata Motors is gearing up for a significant expansion of its electric vehicle endeavours in the near future. The company has confirmed its plans to introduce a total of four electric vehicles by the start of 2024. Out of these four EVs, three are set to be

Renewable Energy Receives Multi-Million Backing To Enhance The UK’s Energy Security

03 Aug, 2023: The UK’s Energy Security Secretary, Grant Shapps revealed that the government will be providing an additional £22 million in support for renewable energy projects through the Contracts for Difference scheme, which will bring the total budget allocated for this auction to £227 million. The Contracts for

Breakthrough In Gene Editing: Scientists Uncover New Role For CRISPR-Cas System

02 Aug, 2023: A research team led by Professor Dr. Alexander Probst has made a groundbreaking discovery that archaea, which are microorganisms bearing resemblance to bacteria, employ the CRISPR-Cas system as a defence mechanism against parasites. The researchers arrived at this conclusion by conducting an in-depth genomic analysis, encompassing more

GRIDSERVE Secures £500+ Million In Green Financing For Expansion Of The UK EV Charging Network

July 26, 2023: GRIDSERVE, a British sustainable energy company, reveals a substantial amount of certified green funding, totalling over five hundred million pounds, aimed at expediting the shift towards net zero transportation. This significant investment will fuel a massive expansion of their Electric Vehicle (EV) charging infrastructure across the United

Exploring Europe’s Disruptive Biotechnology Landscape

In the dynamic realm of biotechnology, Europe stands as a vibrant hub of innovation, harbouring a diverse array of pioneering companies that have propelled the industry to unprecedented heights. From groundbreaking advancements in genomics and personalised medicine to cutting-edge developments in agricultural biotechnology, European biotech firms have continually pushed the

Eventackle | Intelligence © 2026